This research shows how progranulin disrupts macrophage efferocytosis in renal fibrosis, suggesting new therapeutic targets.
PGRN inhibits macrophage efferocytosis during renal fibrosis by binding and inhibiting PPAR-δ, thereby activating the STAT1/2 signaling pathway and impairing the clearance of apoptotic cells.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: